Portside

How Big Pharma’s focus on blockbuster cancer drugs and the use of patents to maintain monopoly control of drug prices squeezes out research and research models and methods leading to potential treatments that are more affordable.

India's Intellectual Property Appellate Board allows license for generic cancer drug at fraction of cost of Bayer's.